The global dacryocystitis market is projected to grow at a significant CAGR during the forecast period. Dacryocystitis is an in?ammation of the lacrimal sac and duct. It may be congenital or acquired. Acquired dacryocystitis assumes two main forms including acute and chronic. The primary factors that drive the growth of the market include increased prevalence of eye infections and increasing clinical research along with novel product launches. Additionally, it is also a crucial cause of ocular morbidity, both in children and adults. Hence, it requires special attention concerning the initiation of the appropriate treatment at the earliest. 

Further, as per the studies by IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), chronic dacryocystitis is more common than acute dacryocystitis but also has several stages of presentation like epiphora, mucoid discharge, conjunctival hyperemia, and chronic conjunctivitis. Thus, the seriousness regarding the treatment of such eye-related disorders is likely to create scope for market growth during the forecast period. 

Despite, the use of laser in dacryocystitis treatment is effective and safe which results in the treatment of various eye conditions; and the use of a laser is more advantageous as compared to other treatments for the surgery, a minute mishandling of the device can cause severe damage to the patient. Hence, skilled labor is required for the operation, and a shortage of which, may challenge the growth of the market during the forecast period. 

Segmental Outlook

The global dacryocystitis market is segmented on the basis of indication into acute, chronic, and others including congenital.  The acute dacryocystitis segment is projected to hold significant share in the market during the forecast period. The segmental growth is attributed to the increased cases of acute dacryocystitis amongst the people. Additionally, symptoms of acute dacryocystitis start earlier as compared with other indications of dacryocystitis, and people suffering from acute dacryocystitis experience more pain for which medication and proper treatment is required. Thus, the acute dacryocystitis segment is likely to witness growth during the forecast period. 

Global Dacryocystitis Market by Indication, 2019 (%)

Regional Outlook

The global dacryocystitis market is geographically segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to be the significantly growing region in the market. The regional growth of the market is attributed to the well-developed healthcare industry and the presence of leading medical laser manufactures is also attributing to the growth of the market. The US and Canada are the major countries in the region that provide a significant contribution to the growth of the market. The US is the major contributor to the market due to the presence of various government initiatives, reforms, policies, and regulations for the support of the advanced treatment of eyes. As per the studies conducted by the Texas, US-based ophthalmologist Dr. Grant D Gilliland, females are mostly affected by the disease as compared to males. Thus, rapid R&D activities regarding the dacryocystitis are likely to significantly contributes to market growth during the forecast period. 

Global Dacryocystitis Market, by Region 2019 (%)

Market Players Outlook

Some of the players operating in the global dacryocystitis market include  Pfizer Inc., Cigna, Novartis International AG, Akorn Inc., Alembic Pharmaceuticals, and others. These are the key companies adopting several organic and inorganic growth strategies such as product launches & developments, partnerships, agreements, and acquisitions to strengthen their product portfolios and maintain a competitive position in the global dacryocystitis market. In April 2019, Alembic Pharmaceuticals received approval from the US FDA for its Abbreviated New Drug Application (ANDA) Tobramycin Ophthalmic Solution USP, 0.3%.

The Report Covers

• Market value data analysis of 2019 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global dacryocystitis market. Based on the availability of data, information related to products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.